Your browser is no longer supported. Please, upgrade your browser.
Settings
NURO NeuroMetrix, Inc. daily Stock Chart
NURO [NASD]
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-7.66 Insider Own2.70% Shs Outstand8.99M Perf Week11.85%
Market Cap6.02M Forward P/E- EPS next Y-0.39 Insider Trans5.51% Shs Float8.18M Perf Month8.05%
Income-34.80M PEG- EPS next Q-0.27 Inst Own5.70% Short Float5.47% Perf Quarter-5.63%
Sales12.00M P/S0.50 EPS this Y6.10% Inst Trans- Short Ratio2.32 Perf Half Y-55.03%
Book/sh0.98 P/B0.68 EPS next Y58.10% ROA- Target Price4.50 Perf Year-63.19%
Cash/sh0.77 P/C0.87 EPS next 5Y15.00% ROE- 52W Range0.52 - 2.36 Perf YTD-9.29%
Dividend- P/FCF- EPS past 5Y34.90% ROI- 52W High-71.61% Beta0.23
Dividend %- Quick Ratio3.00 Sales past 5Y3.00% Gross Margin40.90% 52W Low28.80% ATR0.06
Employees44 Current Ratio3.40 Sales Q/Q87.00% Oper. Margin- RSI (14)55.86 Volatility18.38% 9.83%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume4.34 Prev Close0.63
ShortableYes LT Debt/Eq0.00 EarningsApr 20 BMO Payout- Avg Volume192.82K Price0.67
Recom2.00 SMA208.29% SMA505.76% SMA200-39.06% Volume837,184 Change5.69%
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
Apr-21-17 07:26PM  Edited Transcript of NURO earnings conference call or presentation 20-Apr-17 12:00pm GMT Thomson Reuters StreetEvents +5.69%
10:50AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017 Capital Cube
Apr-20-17 07:00AM  NeuroMetrix Reports Q1 2017 Financial Results Business Wire -5.37%
Apr-19-17 08:30AM  NeuroMetrix Review Ahead of Thursday's Earnings Call Accesswire -5.65%
Apr-18-17 11:34AM  NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond Business Wire +16.70%
Apr-13-17 10:00AM  NeuroMetrix Named a 50+ Innovation Leader Business Wire
Apr-12-17 10:52AM  NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call Business Wire +5.26%
Mar-17-17 12:01PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube +6.25%
12:01PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
Mar-15-17 11:55AM  NeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting Business Wire
Mar-01-17 12:20PM  NeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017 Business Wire
Feb-28-17 06:39PM  NEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -5.32%
Feb-21-17 11:00AM  NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy Business Wire
Feb-15-17 01:04PM  NEUROMETRIX, INC. Financials
Feb-09-17 05:03PM  NEUROMETRIX, INC. Files SEC form 10-K, Annual Report
Feb-03-17 05:12PM  NEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
Jan-27-17 09:55AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017 Capital Cube -5.83%
09:55AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017
Jan-26-17 08:00AM  NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today +6.85%
07:09AM  NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q4 2016 NeuroMetrix Inc Earnings Release - Before Market Open
07:00AM  NeuroMetrix Reports Q4 and Full Year 2016 Financial Results Business Wire
Jan-20-17 09:40AM  NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call Business Wire
Jan-10-17 07:00AM  NeuroMetrix Reports Strong Quell Demand in Q4 2016 Business Wire +10.89%
Jan-06-17 09:25AM  NeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine Business Wire
Jan-05-17 10:34AM  NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants Business Wire
Jan-03-17 03:14PM  NeuroMetrix to Present at Biotech Showcase 2017 Business Wire
12:00PM  CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain Business Wire
Dec-29-16 06:03AM  NEUROMETRIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit -7.31%
Dec-28-16 03:43PM  NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock and Warrants Business Wire +11.55%
Dec-22-16 04:00PM  NeuroMetrix Announces Participation in CES 2017 Business Wire
Dec-20-16 08:00AM  NeuroMetrix Announces $26.5 Million Public Offering Business Wire -27.78%
Dec-15-16 11:00AM  NeuroMetrix Reports Expanded Media Coverage for Quell Wearable Pain Relief Business Wire
Dec-13-16 11:00AM  NeuroMetrix Announces That Quell Is Featured in Huffingtons New Thrive Global Platform Business Wire
Dec-12-16 10:51AM  NeuroMetrix President and Chief Executive Officer Dr. Gozani to Speak at 2016 Connected Health Conference Business Wire
Dec-08-16 02:44PM  NEUROMETRIX, INC. Files SEC form 8-K, Other Events +10.69%
Dec-07-16 12:05PM  NeuroMetrix Announces Quell Now Available on Amazon.com through Amazon Launchpad Business Wire
Nov-30-16 07:00AM  NeuroMetrix to Present at the LD Micro Invitational Conference on December 6, 2016 Business Wire -6.20%
Nov-29-16 07:00AM  NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device Business Wire -5.82%
Nov-22-16 10:05AM  NeuroMetrix Announces That Quell Will Be Featured on The Henry Ford Innovation Nation Business Wire -6.30%
Nov-16-16 07:00AM  NeuroMetrix Quell Device Makes Second Appearance at American Society of Regional Anesthesias Annual Pain Medicine Meeting Business Wire +6.09%
Nov-15-16 07:00AM  NeuroMetrix Reports DPNCheck Introduction at the Annual Meeting of the China Diabetes Society Business Wire
Nov-10-16 08:51AM  NeuroMetrix Chief Commercial Officer Frank McGillin to Present Quell Wearable Pain Relief Technology at 16th Annual Diabetes Technology Meeting Business Wire -5.83%
Nov-08-16 11:36AM  NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer Business Wire
Oct-31-16 05:30PM  NEUROMETRIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-27-16 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology Business Wire
Oct-25-16 01:11PM  NeuroMetrix to Present at 2016 Sidoti Emerging Growth Convention Business Wire
Oct-24-16 10:52AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
Oct-20-16 01:48PM  Edited Transcript of NURO earnings conference call or presentation 20-Oct-16 12:00pm GMT
08:00AM  NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today
07:13AM  NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q3 2016 NeuroMetrix Inc Earnings Release - Before Market Open
07:00AM  NeuroMetrix Reports Q3 2016 Financial Results Business Wire
Oct-18-16 01:02PM  NeuroMetrix Announces Participation at the 2016 Partners Connected Health Symposium Business Wire
Oct-13-16 01:50PM  NeuroMetrix, Inc. Announces Date for 2016 Third Quarter Financial Results Conference Call Business Wire
Oct-10-16 01:04PM  NeuroMetrix Announces Participation in Discover Blue: New York City Bluetooth Event Business Wire
Oct-06-16 12:44PM  NeuroMetrix to Present at 5th Annual Diabetic Peripheral Neuropathy Fellowship for Chinese Physicians at the University of Sheffield Business Wire
Oct-05-16 07:00AM  NeuroMetrix to Sponsor Study Assessing the Impact of Quell Technology on Chronic Low Back Pain Business Wire
Sep-28-16 11:43AM  NeuroMetrix Announces Frank McGillin Will Speak at the 2016 Wearable Technology Show Business Wire
Sep-22-16 07:00AM  NeuroMetrix Announces Quell Fibromyalgia Pilot with Synovation Medical Group Business Wire
Sep-20-16 07:00AM  NeuroMetrix Reports Progress on Quell Availability within the Veterans Health Administration Business Wire
Sep-16-16 12:39PM  NeuroMetrix Wins Electronics Retailer Association Award for Quell TV Advertising Business Wire
Sep-13-16 07:00AM  NeuroMetrix Reports Final Approval to Market DPNCheck in China Business Wire
Sep-08-16 07:00AM  NeuroMetrix Announces Quell Dispensing Partnership with Comprehensive Pain Specialists Business Wire
Sep-07-16 06:45PM  Weekly CFO Buys Highlights
Sep-06-16 11:00AM  NeuroMetrix Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016 Business Wire
Sep-01-16 11:44AM  NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China Business Wire +6.80%
Aug-30-16 07:00AM  NeuroMetrix Launches New Website to Support Growth of Quell Wearable Pain Relief Technology Business Wire
Aug-25-16 07:00AM  NeuroMetrix Announces That Quell Will Be Featured in the Target Open House Business Wire
Aug-22-16 12:21PM  NeuroMetrix Celebrates 10,000 Quell Facebook Fans with Pain Awareness Month Contest Business Wire
Aug-16-16 07:00AM  NeuroMetrix Commentary on Strategic and Business Partnerships for Quell Wearable Pain Relief Technology Business Wire
Aug-03-16 09:10AM  NeuroMetrix To Present Quell Wearable Pain Technology at National Association of Chain Drug Stores Total Store Expo Business Wire
Aug-02-16 10:22AM  NeuroMetrix Reports that the Quell Health Cloud Has Collected Over 1 Million Hours of Quell Therapy and Health Data Business Wire -5.63%
Jul-28-16 02:11PM  NeuroMetrix Reports Recent Media Coverage for Quell Business Wire
Jul-22-16 12:31PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016
Jul-21-16 07:22PM  Edited Transcript of NURO earnings conference call or presentation 21-Jul-16 12:00pm GMT
08:00AM  NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today
07:34AM  NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q2 2016 NeuroMetrix Inc Earnings Release - Before Market Open
07:00AM  NeuroMetrix Reports Q2 2016 Financial Results and Highlights Business Wire
Jul-20-16 10:18AM  Medical Product Earnings on Jul 21: ABAX, ATHN, NURO, SYK
Jul-14-16 07:00AM  NeuroMetrix, Inc. Announces Date for 2016 Second Quarter Financial Results Conference Call Business Wire
Jul-13-16 07:00AM  NeuroMetrix Expands DPNCheck Commercialization in Mexico Business Wire
Jul-12-16 11:00AM  NeuroMetrix Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting Business Wire
Jul-07-16 07:00AM  NeuroMetrix Announces Launch of Quell Sport Electrode Business Wire
Jul-06-16 07:00AM  NeuroMetrix Reports Peer-Reviewed Publication of Initial Quell Study Business Wire
Jun-28-16 01:28PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
11:21AM  NeuroMetrix Announces Quell Distribution Agreement with WBC Group Business Wire
07:05AM  Coverage initiated on NeuroMetrix by Rodman & Renshaw
Jun-27-16 12:19PM  NeuroMetrix to Sponsor Clinical Study at the Scripps Translational Science Institute Assessing the Impact of Quell Technology on Opioid Use and Pain in Cancer Patients Business Wire
Jun-22-16 07:00AM  NeuroMetrix Submits CE Mark Application for Quell Wearable Pain Relief Device Business Wire
Jun-21-16 07:00AM  NeuroMetrix Showcases Quell Technology at the Western Foot & Ankle Conference Business Wire
Jun-14-16 02:26PM  NeuroMetrix Announces Quell Distribution in Canada Business Wire -5.26%
Jun-10-16 11:31AM  NeuroMetrix Reports Executive Stock Transactions during May 2016 Business Wire
Jun-09-16 07:00AM  NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies Business Wire
Jun-08-16 04:27PM  NeuroMetrix Closes $21.3 Million At-The-Market Private Placement of Preferred Stock and Warrants and Redeems $13.8 Million of Outstanding Preferred Stock Business Wire
Jun-06-16 07:00AM  NeuroMetrix Celebrates 20 Year Anniversary Business Wire
Jun-03-16 04:12PM  NEUROMETRIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit +15.33%
Jun-02-16 04:18PM  NeuroMetrix Announces $21.3 Million at the Market Private Placement of Preferred Stock and Warrants Business Wire +5.73%
07:00AM  NeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores Business Wire
NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; the SENSUS pain therapy device, a prescription neurostimulation device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies. The company offers its products to consumers, patients, retail merchandisers, health care professionals, durable medical equipment suppliers, physicians, clinics, hospitals, managed care organizations, independent distributors, retail health businesses, endocrinologists, podiatrists, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neuro surgeons primarily in the United States, Europe, Asia, the Middle East, and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gozani ShaiPresident & CEONov 01Buy1.313,0003,923150,909Nov 01 04:45 PM
HIGGINS THOMAS TSenior Vice President, CFOOct 28Buy1.323,0003,95173,309Oct 28 04:53 PM
Gozani ShaiPresident & CEOOct 27Buy1.326,0007,946147,909Oct 27 05:29 PM
HIGGINS THOMAS TSenior Vice President, CFOAug 31Buy1.411,4001,97470,309Aug 31 05:21 PM
Gozani ShaiPresident & CEOAug 18Buy1.495,0007,450141,909Aug 19 10:00 AM
HIGGINS THOMAS TSenior Vice President, CFOAug 12Buy1.452,0002,90068,909Aug 15 10:00 AM
Gozani ShaiPresident & CEOJun 01Buy1.712,5004,273139,409Jun 01 05:12 PM
MCGILLIN FRANCIS XSenior VP, ConsumerMay 23Buy1.651,0001,65037,886May 23 05:04 PM
Gozani ShaiPresident & CEOMay 19Buy1.554,5006,975136,909May 19 05:08 PM
Gozani ShaiPresident & CEOMay 18Buy1.557,50011,625132,409May 19 05:08 PM